期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性肾脏病血管钙化机制的研究进展 被引量：3

原文传递
导出
摘要 慢性。肾脏病（CKD）是严重危害人类健康的常见病，已成为全球公共健康问题。流行病学资料显示，心血管疾病（cardiovascular disease，CVD）是CKD最常见的严重并发症。其中，血管钙化广泛发生于CKD患者中，是导致其CVD发病率和病死率显著增加的重要危险因素。因此，深入探讨CKD血管钙化的发病机制，对于积极防治CKD的心血管并发症具有重要意义。
作者 伍敏
机构地区 东南大学附属中大医院.肾脏科东南大学肾脏病研究所
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第34期2759-2761,共3页 National Medical Journal of China
关键词 血管钙化机制 慢性肾脏病 流行病学资料 心血管并发症 心血管疾病 严重并发症 CKD 人类健康
分类号 R692 [医药卫生—泌尿科学]
  • 相关文献

参考文献40

  • 1Sage AP, Tintut Y, Demer LL. Regulatory mechanisms invascular calcification. Nat Rev Cardiol, 2010, 7: 528-536.
  • 2Russo D, Palmiero G, De-Blasio AP, et al. Coronary artery' calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis, 2004, 44 : 1024 -1030.
  • 3Tomiyama C, Carvalho AB, Higa A, et al. Coronary calcification is associated with lower bone formation rate in CKD patients not yet in dialysis treatment. J Bone Miner Res, 2010, 25: 499-504.
  • 4Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N, et al. Vascular calcifications : pathogenesis, management, and impact on clinical outcomes. J Am Soe Nephrol, 2006, 17: S267-S273.
  • 5Amann K. Media calcification and intima calcification are distinct entities in chronic kidney disease. Clin J Am Soc Nephrol, 2008, 3 : 1599-1605.
  • 6Persy V, D'Haese P. Vascular calcification and bone disease: the calcification paradox. Treads Mol Med,2009,15:405-416.
  • 7London GM, Guerin AP, Marchais SJ, et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant, 2003, 18 : 1731-1740.
  • 8Kovesdy CP, Ureche V, Lu JL, et al. Outcome predictability of serum alkaline phosphatase in men with pre-dialysis CKD. Nephrol Dial Transplant, 2010, 25: 3003-3011.
  • 9Skolnick AH, Osranek M, Formica P, et al. Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol, 2009, 104 : 122-124.
  • 10Thompson B, Towler DA. Arterial calcification and bone physiology: role of the bone-vascular axis. Nat Rev Endocrinol, 2012, 8 : 529-543.

二级参考文献28

  • 1李占园,刘毅,王文靖,徐玉兰.高磷对牛血管平滑肌细胞钙化及其骨桥素分泌的影响[J].中华肾脏病杂志,2006,22(1):52-53. 被引量：1
  • 2Coladonato J. Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol, 2005, 16 Suppl 2: S107- S114.
  • 3Block GA. Control of serum phosphorus: implications for coronary artery calcification and calcific uremic arteriolopathy (calciphylaxis). Curr Opin Nephrol Hypertens, 2001, 10: 741-747.
  • 4Ishimura E, Okuno factors for vascular between diabetics S, Taniwaki H, et al. Different risk calcification in end-stage renal disease and nondiabetics: the respective importance of glycemic and phosphate control. Kidney Blood Press Res, 2008, 31: 10-15.
  • 5Wang N, Yang J, Yu X, et al. Radial artery calcification in end-stage renal disease patients is associated with deposition of osteopontin and diminished expression of alpha-smooth muscle actin. Nephrology (Carlton), 2008, 13: 367-375.
  • 6Li X, Giachelli CM. Sodium-dependent phosphate cotransporters and vascular calcification. Curr Opin Nephrol Hypertens, 2007, 16: 325-328.
  • 7Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin J Am Soc Nephrol, 2008, 3: 836-843.
  • 8Prince M, Banerjee C, Javed A, et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypie markers during the growth and differentiation of human osteoblasts. J Cell Bioehem, 2001, 80: 424-440.
  • 9Pagani F, Francucci CM, Moro L. Markers of bone turnover: biochemical and clinical perspectives. J Endoerinol Invest, 2005, 28: 8-13.
  • 10Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res, 2000, 87: e10-e17.

共引文献19

同被引文献37

  • 1Sbobeiri N, Adams MA, Holden RM. Phosphate: an old bone molecule but new cardiovascular risk factor[J]. Br J Clin Pharmacol, 2014,77 ( 1 ) : 39-54.
  • 2Marks J, Debnam ES, Unwin RJ. The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease[J]. Curr Opin Nephrol Hypertens,2013, 22(4) : 481-487.
  • 3Waheed AA, Pedraza F, Lenz O, et al. Phosphate control in end-stage renal disease: barriers and opportunities[J]. Nephrol Dial Transplant,2013,28(12) :2961-2968.
  • 4Palmer SC, Hayen A, Macaskill P, et al. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis [J]. JAMA,2011,305(11): 1119-1127.
  • 5Bellasi A, Mandreoli M, Baldrati L, et al. Chronic kidney disease progression and outcome according to serum phosphorus in mild to-moderate kidney dysfunction [J]. Clin J Am Soc Nephrol, 2011,6(4) :883-891.
  • 6Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population[J]. Nephrol Dial Transplant, 2011, 26 (6): 1948- 1955.
  • 7Voormolen N, Noordzij M, Grootendorst DC, et al. High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients[J]. Nephrol Dial Transplant, 2007,22(10) :2909-2916.
  • 8Chue CD, Edwards NC, Davis LJ, et al. Serum phosphate but not pulse wave velocity predicts decline in renal function in patients with early chronic kidney disease[J]. Nephrol Dial Transplant, 2011,26 (8): 2576-2582.
  • 9Sekiguchi S, Suzuki A, Asano S, et al. Phosphate overload induces podocyte injury via type III Na-dependent phosphate transporter[J]. Am J Physiol Renal Physiol, 2011,300 (4) :F848-856.
  • 10Shroff R. Phosphate is a vascular toxin[J]. Pediatr Nephrol, 2013,28(4) :583-593.

引证文献3

二级引证文献38

中华医学杂志
2013年 第34期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部